CTRI/2020/05/025156已完成3 期
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush-64) add-on therapy for patients with COVID-19 infection (Stage I)-A Randomized controlled clinical trial
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of 18-60 yrs of age, clinically diagnosed with corona virus disease 2019 by RTPCR test coming under stage I- mild (Early infection)- Group A, B, C as per TREATMENT PROTOCOL FOR CONFIRMED COVID-19 PATIENTS (Maharashtra Health Services_15 April 2020.)
- •2.Participants who can take medicines orally.
- •3.Patients willing to provide signed informed consent.
排除标准
- •1.Pregnant, Lactating women, patients with CKD (Chronic Kidney Disease).
- •2.Not willing to participate in the study.
研究者
相似试验
尚未招募
不适用
Evaluation of Role of Ayurvedic Drug- Guduchi Ghan Vati in the treatment of COVID-19 related illnessCTRI/2020/05/025370Dr SR Rajasthan Ayurved University Jodhpur
已完成
2 期
Evaluation of Efficacy and Safety of Ayurveda Intervention (Ayush -64) in the management of COVID-19 infection (Asymptomatic &Mild to Moderate symptomsCTRI/2020/05/025338Central Council For Research in Ayurvedic Sciences40
尚未招募
2 期
Study of use of Ayurveda Intervention (Ayush-64) in COVID 19CTRI/2020/06/026002ational Institute of Ayurveda
尚未招募
不适用
Therapeutic role of Ayurvedic interventions in Amavata(Rheumatoid arthritis) with special reference to gut microbiotaCTRI/2020/10/028746AMRIT GODBOLE
已完成
2 期
Clinical trial of CIM-Meg19 in COVID-19 patientsCTRI/2021/05/033543Ms Meghdoot Gramodyog Sewa Sansthan80